CD38 and COVID-19: In circulating T cells, both CD4+ and CD8+ T cells in the patient with myopericarditis after COVID-19 vaccine exhibited an activated phenotype defined by CD38+HLA-DR+ and PD-1+Ki-67+ compared to healthy and vaccine control groups (Figures 2D–G).